Insiders · Profile

SR ONE CAPITAL MANAGEMENT, LLC

10% owner at Odyssey Therapeutics · 10% owner at Avalyn Pharma · 10% owner at Zenas BioPharma. Filing since 16 Sep 2024. CIK 0001853723

ODTX Odyssey Therapeutics, Inc. 10% owner · 2 trades AVLN Avalyn Pharma Inc. 10% owner · 1 trade ZBIO Zenas BioPharma, Inc. 10% owner · 2 trades

Company

Date

Role

Action

Shares

Amount

Of holding

ODTX Odyssey Therapeutics, Inc.

11 May 2026

10% owner

Bought

555,555

$10.00M

43.5%

ODTX Odyssey Therapeutics, Inc.

11 May 2026

10% owner

Sold at will

1,780

$32.04K

0.4%

AVLN Avalyn Pharma Inc.

1 May 2026

10% owner

Bought

555,555

$10.00M

34.1%

ZBIO Zenas BioPharma, Inc.

9 Oct 2025

10% owner

Bought

126,315

$2.40M

7.1%

ZBIO Zenas BioPharma, Inc.

16 Sep 2024

10% owner

Bought

2,235,294

$38.00M

opened

5 decisions on file.